We are live on
!
Find out more
BOTW
Bank of the West Portfolio holdings
AUM
$851M
1-Year Est. Return
15.39%
This Fund
S&P 500
This Quarter
Est. Return
+3.71%
1 Year Est. Return
-15.39%
3 Year Est. Return
+35.37%
5 Year Est. Return
+63.47%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$4.83M
(-0.56%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
28.32%
Holding
286
New
8
Increased
82
Reduced
156
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$3.33M |
| 2 |
Elevance Health
ELV
|
+$2.96M |
| 3 |
Simon Property Group
SPG
|
+$1.48M |
| 4 |
Dow Inc
DOW
|
+$1.02M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$790K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$4.05M |
| 2 |
American Tower
AMT
|
+$3.91M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$3.8M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$2.27M |
| 5 |
Biogen
BIIB
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.22% |
| 2 | Financials | 11.48% |
| 3 | Healthcare | 9.95% |
| 4 | Communication Services | 8.26% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
51
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.56M | 0.54% |
34,841
+1,384
| +4% | +$178K |
|
|
SCHW
52
Charles Schwab
SCHW
$187B
| $4.54M | 0.53% |
112,875
+18,132
| +19% | +$790K |
|
53
Morgan Stanley
MS
$339B
| $4.51M | 0.53% |
102,928
+5,556
| +6% | +$248K |
|
54
General Dynamics
GD
$107B
| $4.37M | 0.51% |
24,024
+3,319
| +16% | +$571K |
|
55
CVS Health
CVS
$119B
| $4.35M | 0.51% |
79,824
-3,941
| -5% | -$212K |
|
|
56
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $4.29M | 0.5% |
34,528
-18,930
| -35% | -$2.27M |
|
57
Cognizant
CTSH
$26.4B
| $4.27M | 0.5% |
67,361
+801
| +1% | +$52.6K |
|
58
Tyson Foods
TSN
$19.8B
| $4.2M | 0.49% |
52,013
-2,476
| -5% | -$191K |
|
|
APC
59
DELISTED
Anadarko Petroleum
APC
| $4.13M | 0.48% |
58,462
-6,173
| -10% | -$414K |
|
60
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$365M
| $4.12M | 0.48% |
137,938
-32,801
| -19% | -$979K |
|
61
Blackrock
BLK
$178B
| $4.05M | 0.48% |
8,623
+430
| +5% | +$195K |
|
62
Labcorp
LH
$26.1B
| $4.05M | 0.48% |
27,240
-4,387
| -14% | -$612K |
|
63
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
| $3.98M | 0.47% |
66,864
-5,812
| -8% | -$340K |
|
64
AbbVie
ABBV
$439B
| $3.89M | 0.46% |
53,474
-3,429
| -6% | -$270K |
|
65
Verizon
VZ
$196B
| $3.85M | 0.45% |
67,489
-7,781
| -10% | -$448K |
|
66
Capital One
COF
$135B
| $3.83M | 0.45% |
42,181
-225
| -0.5% | -$20.1K |
|
67
Walt Disney
DIS
$178B
| $3.78M | 0.44% |
27,043
-4,717
| -15% | -$626K |
|
|
68
Simon Property Group
SPG
$72B
| $3.73M | 0.44% |
23,336
+8,581
| +58% | +$1.48M |
|
69
Berkshire Hathaway Class B
BRK.B
$1.11T
| $3.67M | 0.43% |
17,234
+291
| +2% | +$60.2K |
|
70
iShares MBS ETF
MBB
$39B
| $3.67M | 0.43% |
34,059
-6,999
| -17% | -$745K |
|
|
71
Corteva
CTVA
$50.8B
| $3.66M | 0.43% |
+123,804
| New | +$3.33M |
|
72
McDonald's
MCD
$193B
| $3.64M | 0.43% |
17,543
-337
| -2% | -$66.8K |
|
|
AGN
73
DELISTED
Allergan plc
AGN
| $3.47M | 0.41% |
20,745
-1,589
| -7% | -$220K |
|
74
Becton Dickinson
BDX
$49.2B
| $3.4M | 0.4% |
13,845
+1,417
| +11% | +$329K |
|
75
PepsiCo
PEP
$188B
| $3.26M | 0.38% |
24,840
-793
| -3% | -$102K |
|
Similar funds
SGA
PIM
LWAC
S
BS
TFS
AAM
SBL
Bank of the West's Q2 2019 Portfolio in Review
As of Q2 2019, Bank of the West held 286 positions worth $851M, down 0.56% from $856M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bank of the West withdrew a net $30.4M in Q2 2019, closing 13 positions and reducing 156 holdings. Its most notable exit was Fluor, an estimated $342K position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of the West opened a new position in Corteva worth $3.66M.
- Bank of the West's largest Q2 2019 buy was Corteva: 123,804 shares worth $3.66M.
- Bank of the West added most to Elevance Health in Q2 2019, an estimated $2.96M increase.
- Bank of the West's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $4.05M.
- Bank of the West fully exited Fluor in Q2 2019, selling an estimated $342K.
- Bank of the West's ten largest holdings make up 28% of its $851M portfolio in Q2 2019.
- Bank of the West opened 8 new positions and closed 13 in Q2 2019.
- Bank of the West's portfolio value fell 0.56% quarter-over-quarter to $851M.
Based on Bank of the West's 13F filing for Q2 2019, filed 18 Jul 2019.